The results showed that the expression of GPSM3 was significantly upregulated in the IDH wild-type LGG and 1p19q codeletion LGG compared to that in IDH-mutant gliomas and 1p19q non-codeletion LGG (Figure 1H,I). This evidence concerns the gene GPSM3 and central nervous system cancer.